H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Viking Therapeutics (VKTX – Research Report) today and set a price target ...

In a report released today, Joseph Pantginis from H.C. Wainwright maintained a Buy rating on Lexicon Pharmaceuticals (LXRX – Research Report), ...

Analysts at HC Wainwright issued their FY2029 earnings estimates for shares of Corbus Pharmaceuticals in a note issued to investors on Monday, February 10th. HC Wainwright analyst A. Maldonado expects ...

Largo (NYSE:LGO – Get Free Report) had its target price cut by investment analysts at HC Wainwright from $4.20 to $3.70 in a report released on Wednesday,Benzinga reports. The firm currently has a ...

Detailed price information for Fate Therapeutics (FATE-Q) from The Globe and Mail including charting and trades.

Carl Spana; President, Chief Executive Officer, Director; Palatin Technologies Inc Stephen Wills; Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer, Secretary; ...

Bonny Simi, President of Operations at Joby Aviation , Inc. (NYSE:JOBY), recently executed a stock transaction that saw the sale of 8,628 shares of common stock. The shares were sold on February 13, ...

CFO Beth Jantzen reported total revenues of $1.2 million for Q1 2025, a year-over-year increase driven by higher product revenue from DNA Tagging and increased isotopic testing services. Operating ...

Shares of Coinbase Global Inc (NASDAQ: COIN) plunged despite upbeat Q4 revenues. Analysts maintain Buy/Nuetral ratings with price targets as high as $475.

LIXTE Biotechnology (LIXT) announced the closing of its previously announced registered direct offering priced at-the-market ...